The Facebook post says the triple-agonist shot slows stomach emptying, which can be risky under anesthesia. It also notes the drug has no FDA approval yet.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
In 60 heart failure patients with implanted sensors, semaglutide or tirzepatide tracked with lower pressures and yearly hospitalizations falling from 1.2 to 0.3, researchers report.
A clinic explainer sorting the brand names, Ozempic and Wegovy versus Mounjaro and Zepbound, and how each drug works.
Loading…